SODIUM 4-HYDROXYBUTYRATE
- ₹2231.1
- Product name: SODIUM 4-HYDROXYBUTYRATE
- CAS: 502-85-2
- MF: C4H9NaO3
- MW: 128.1
- EINECS:207-953-3
- MDL Number:MFCD00004402
- Synonyms:4-hydroxy-butanoicacimonosodiumsalt ;4-hydroxy-butyricacisodiumsalt ;γ-Hydroxybutyric acid sodium salt;GAMMA-HYDROXYBUTYRIC ACID SODIUM;Sodium4-hydroxybutyrate,98%;Butanoic acid, 4-hydroxy-, monosodium salt;GHB,1.0MG/MLINMETHANOL;Sodium oxybutryrate (gamma)
1 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 1ML
- ManufacturerSigma-Aldrich(India)
- Product numberG-001
- Product descriptionGHB sodium salt solution 1.0?mg/mL in methanol (as salt), ampule of 1?mL, certified reference material, Cerilliant?
- Packaging1ML
- Price₹2231.1
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | G-001 | GHB sodium salt solution 1.0?mg/mL in methanol (as salt), ampule of 1?mL, certified reference material, Cerilliant? | 1ML | ₹2231.1 | 2022-06-14 | Buy |
Properties
Melting point :145-146°C
Flash point :9℃
storage temp. :Controlled Substance, -20°C Freezer
solubility :DMSO (Slightly), Water (Slightly)
form :solid
Merck :13,4840
CAS DataBase Reference :502-85-2(CAS DataBase Reference)
EPA Substance Registry System :Butanoic acid, 4-hydroxy-, monosodium salt (502-85-2)
Flash point :9℃
storage temp. :Controlled Substance, -20°C Freezer
solubility :DMSO (Slightly), Water (Slightly)
form :solid
Merck :13,4840
CAS DataBase Reference :502-85-2(CAS DataBase Reference)
EPA Substance Registry System :Butanoic acid, 4-hydroxy-, monosodium salt (502-85-2)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|
Description
Xyrem is distributed by Jazz Pharmaceuticals, Inc. (Palo Alto, CA). It is an oral solution of sodium oxybate prescribed for narcoleptic patients to treat extreme daytime sleepiness and cataplexy. Xyrem is also known as sodium oxybate which is the same as gamma hydroxybutyric acid (GHB), a drug of abuse. GHB is endogenously produced and present in the central nervous system (CNS) in small concentrations. Accidental overdosing has led to many hospitalizations and deaths. Because of the tendency to abuse GHB, it was classified as a schedule I controlled substance. This meant that GHB had a high potential for abuse and no medical purpose. However, in 2002, because of a series of clinical trials that demonstrated that the compound reduces cataplexy attacks, it was approved for use under the trademark Xyrem. Since GHB had previously been used as a ‘date-rape’ drug, Xyrem is considered a schedule III controlled substance and is distributed in accordance with strict FDA regulations. Xyrem may only be ordered through the ‘Xyrem Success Program.’ Illegal use is punishable under federal and state laws.More related product prices
H-ABU-OME HCL LevetiracetaM IMpurity B 102767-31-7 (2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid 67118-31-4 4-CHLOROBUTYRIC ACID L-2-Aminobutanamide hydrochloride 2-Hydroxypyridine 103765-01-1 103765-03-3 1637-73-6 Sodium citrate SODIUM 2-HYDROXYBUTYRATE Disodium citrate 138-09-0 SODIUM 4-HYDROXYBUTYRATE Sodium gluconateRelated product price
- 102767-31-7
₹56939.5 - 4-CHLOROBUTYRIC ACID
₹4500-21500 - L-2-Aminobutanamide hydrochloride
₹1654-45529.95